Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction

BACKGROUND: Bone-derived mesenchymal stem cell (BMSC) transplantation has been reported to be effective for the treatment of ischemic heart disease, but whether BMSCs are the optimal cell type remains under debate. Increasing numbers of studies have shown that Nestin, an intermediate filament protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Dihan, Liao, Yan, Zhu, Shuang-Hua, Chen, Qiao-Chao, Xie, Dong-Mei, Liao, Jian-Jun, Feng, Xia, Jiang, Mei Hua, He, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487029/
https://www.ncbi.nlm.nih.gov/pubmed/31029167
http://dx.doi.org/10.1186/s13287-019-1217-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487029/
https://www.ncbi.nlm.nih.gov/pubmed/31029167
http://dx.doi.org/10.1186/s13287-019-1217-x

Ejemplares similares